Nasdaq-listed medical device technology company BioSig Technologies announced the launch of a rights issue following its merger with another Nasdaq-listed company, Streamex Exchange Corporation, to publicly issue 3,852,149 common shares at $3.90 per share, raising a total of approximately $15 million to purchase gold bars to advance its gold RWA tokenization.
美国纳斯达克上市的医疗设备技术公司BioSig Technologies宣布与另一家纳斯达克上市公司Streamex Exchange Corporation合并后启动配股募资,以每股3.9美元公开发行3,852,149股普通股,总计募资约1500万美元,以用于购买金条推进其黄金RWA代币化。
BioSig Technologies (BSGM), a medical technology company that just merged with tokenization company Streamex, said it has signed a definitive agreement to raise up to $1.10 billion to fund a gold-backed treasury model and expand its tokenization platform for real-world assets (RWA) like gold and other commodities. Streamex plans to issue tokens backed by gold and other commodities through its platform built on the Solana (SOL) blockchain.
Nasdaq-listed medical technology company BioSig Technologies (BSGM) announced on Monday that it has entered into a $1.10 billion financing agreement with an undisclosed institutional investor to advance its commodity marketplace onchain initiative. The financing includes a $100 million senior secured convertible bond and a $1 billion equity credit line. The financing follows BioSig's completion of its merger with Bahamian firm Streamex Exchange Corporation, marking a strategic shift towards the ...
纳斯达克上市医疗技术公司BioSig Technologies (BSGM)周一宣布,与一家未披露的机构投资者达成总额高达11亿美元的融资协议,用于推动商品市场链上化计划。此次融资包括1亿美元的高级担保可转换债券和10亿美元的股权信用额度。该融资紧随BioSig与巴哈马公司Streamex Exchange Corporation完成合并后进行,标志着公司向真实世界资产代币化方向的战略转型。